tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Pasha Sarraf, 4 are a HOLD (30.77%), 8 are a BUY (61.54%), 1 are a SELL (7.69%).
Analyst Pasha Sarraf, carries an average stock price target met ratio of 70% that have a potential upside of 69.43% achieved within 463 days. Previously, Pasha Sarraf worked at LEERINK, BAML.
Pasha Sarraf’s has documented 23 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VKTX, Viking Therapeutics at 25-Jun-2025.
Analyst best performing recommendations are on ACRS (ACLARIS THERAPEUTICS).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 3/4/2021. The price target of $26 was fulfilled within 15 days with a profit of $4.86 (22.99%) receiving and performance score of 15.33.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-May-2025
$16
$11 (220.00%)
$16
5 months 27 days ago
(19-Mar-2026)
0/11 (0%)
$12.26 (327.81%)
Hold Since 06-Nov-2024
$2
$-3 (-60.00%)
$3
1 years 6 months 19 days ago
(27-Feb-2025)
3/5 (60%)
$0.05 (2.56%)
77
Hold Since 20-Nov-2024
1 years 9 months 26 days ago
(20-Nov-2024)
0/10 (0%)
$23.92 (169.89%)
Hold Since 19-Nov-2024
$8
$3 (60.00%)
1 years 9 months 27 days ago
(19-Nov-2024)
0/4 (0%)
$3.41 (74.29%)
Hold Since 19-Nov-2024
$7
$2 (40.00%)
1 years 9 months 27 days ago
(19-Nov-2024)
0/5 (0%)
$2.41 (52.51%)
